Press Release

Press Release

Choose a Category:

  • Aspira Labs Expands Coverage For Ova1® In California

    AUSTIN, Texas — ASPiRA LABS, a Vermillion company (NASDAQ: VRML), today announced an agreement has been reached with Sacramento-based Sutter Valley Medical Foundation (d/b/a Gould Medical Foundation) for coverage of OVA1, Vermillion’s ovarian cancer risk assessment test commercialized by ASPiRA LABS. “We are pleased to announce OVA1 coverage expansion with Gould Medical Foundation, a California…

  • Vermillion Reports Second Quarter 2016 Results

    AUSTIN, Texas — Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported its financial results for the second quarter ended June 30, 2016. Valerie Palmieri, President and CEO of Vermillion, Inc., stated, “We believe that our performance during the second quarter of 2016 has built a solid foundation for continued success…

  • Vermillion Lands America’s Most Decorated Gymnast and Ovarian Cancer Survivor, Shannon Miller, for its OVA1® Awareness Team

    OVA1 Awareness Team Created to Springboard a National Conversation about Pelvic Mass and the Diagnosis of Ovarian Cancer AUSTIN, Texas – Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the most decorated gymnast in American history has joined its new OVA1 Awareness Team. As a member of Vermillion’s Awareness Team,…

Investor Relations